Olga Moskalenko
Olga Moskalenko has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Julienne Siptroth
High Performance Computing in Life Sciences, Technical University of Applied Sciences Wildau, Wildau, Germany
3 shared publications - Carsten Krumbiegel
BIOMES NGS GmbH, Wildau, Germany
2 shared publications - Heike Pospisil
High Performance Computing in Life Sciences, Technical University of Applied Sciences Wildau, Wildau, Germany
2 shared publications - Ina Koch
Goethe University, Institute of Computer Science, Frankfurt am Main, Germany
2 shared publications - Jörg Ackermann
Department of Molecular Bioinformatics, Institute of Computer Science, Goethe University Frankfurt, Frankfurt am Main, Germany
2 shared publications - Alina Nechyporenko
Technical University of Applied Sciences Wildau image/svg+xml
1 shared publication
Latest Publications
- Open Access
- 9 May 2023
- Published by Springer Nature in Discover Artificial Intelligence
- Vol. 3 (1) , 1-9
Investigation of metabolic pathways from gut microbiome analyses regarding type 2 diabetes mellitus using artificial neural networks
- 9 May 2023
- Published by Springer Nature in Discover Artificial Intelligence
- Vol. 3 (1) , 1-9
Open AccessInvestigation of metabolic pathways from gut microbiome analyses regarding type 2 diabetes mellitus using artificial neural networks
- Open Access
- 17 March 2023
- Published by MDPI AG in Big Data and Cognitive Computing
- Vol. 7 (1) , 51
Classification of Microbiome Data from Type 2 Diabetes Mellitus Individuals with Deep Learning Image Recognition
Microbiomic analysis of human gut samples is a beneficial tool to examine the general well-being and various health conditions. The balance of the intestinal flora is important to prevent chronic gut infections and adiposity, as well as pathological alterations connected to various diseases. The evaluation of microbiome data based on next-generation sequencing (NGS) is complex and their interpretation is often challenging and can be ambiguous. Therefore, we developed an innovative approach for the examination and classification of microbiomic data into healthy and diseased by visualizing the data as a radial heatmap in order to apply deep learning (DL) image classification. The differentiation between 674 healthy and 272 type 2 diabetes mellitus (T2D) samples was chosen as a proof of concept. The residual network with 50 layers (ResNet-50) image classification model was trained and optimized, providing discrimination with 96% accuracy. Samples from healthy persons were detected with a specificity of 97% and those from T2D individuals with a sensitivity of 92%. Image classification using DL of NGS microbiome data enables precise discrimination between healthy and diabetic individuals. In the future, this tool could enable classification of different diseases and imbalances of the gut microbiome and their causative genera.
- 17 March 2023
- Published by MDPI AG in Big Data and Cognitive Computing
- Vol. 7 (1) , 51
Open AccessClassification of Microbiome Data from Type 2 Diabetes Mellitus Individuals with Deep Learning Image Recognition
Microbiomic analysis of human gut samples is a beneficial tool to examine the general well-being and various health conditions. The balance of the intestinal flora is important to prevent chronic gut infections and adiposity, as well as pathological alterations connected to various diseases. The evaluation of microbiome data based on next-generation sequencing (NGS) is complex and their interpretation is often challenging and can be ambiguous. Therefore, we developed an innovative approach for the examination and classification of microbiomic data into healthy and diseased by visualizing the data as a radial heatmap in order to apply deep learning (DL) image classification. The differentiation between 674 healthy and 272 type 2 diabetes mellitus (T2D) samples was chosen as a proof of concept. The residual network with 50 layers (ResNet-50) image classification model was trained and optimized, providing discrimination with 96% accuracy. Samples from healthy persons were detected with a specificity of 97% and those from T2D individuals with a sensitivity of 92%. Image classification using DL of NGS microbiome data enables precise discrimination between healthy and diabetic individuals. In the future, this tool could enable classification of different diseases and imbalances of the gut microbiome and their causative genera.
- Open Access
- 13 February 2023
- Published by Springer Nature in International Microbiology
- Vol. 26 (3) , 601-610
Variation of butyrate production in the gut microbiome in type 2 diabetes patients
Background: Diabetes mellitus type 2 is a common disease that poses a challenge to the healthcare system. The disease is very often diagnosed late. A better understanding of the relationship between the gut microbiome and type 2 diabetes can support early detection and form an approach for therapies. Microbiome analysis offers a potential opportunity to find markers for this disease. Next-generation sequencing methods can be used to identify the bacteria present in the stool sample and to generate a microbiome profile through an analysis pipeline. Statistical analysis, e.g., using Student’s t-test, allows the identification of significant differences. The investigations are not only focused on single bacteria, but on the determination of a comprehensive profile. Also, the consideration of the functional microbiome is included in the analyses. The dataset is not from a clinical survey, but very extensive. Results: By examining 946 microbiome profiles of diabetes mellitus type 2 sufferers (272) and healthy control persons (674), a large number of significant genera (25) are revealed. It is possible to identify a large profile for type 2 diabetes disease. Furthermore, it is shown that the diversity of bacteria per taxonomic level in the group of persons with diabetes mellitus type 2 is significantly reduced compared to a healthy control group. In addition, six pathways are determined to be significant for type 2 diabetes describing the fermentation to butyrate. These parameters tend to have high potential for disease detection. Conclusions: With this investigation of the gut microbiome of persons with diabetes type 2 disease, we present significant bacteria and pathways characteristic of this disease.
- 13 February 2023
- Published by Springer Nature in International Microbiology
- Vol. 26 (3) , 601-610
Open AccessVariation of butyrate production in the gut microbiome in type 2 diabetes patients
Background: Diabetes mellitus type 2 is a common disease that poses a challenge to the healthcare system. The disease is very often diagnosed late. A better understanding of the relationship between the gut microbiome and type 2 diabetes can support early detection and form an approach for therapies. Microbiome analysis offers a potential opportunity to find markers for this disease. Next-generation sequencing methods can be used to identify the bacteria present in the stool sample and to generate a microbiome profile through an analysis pipeline. Statistical analysis, e.g., using Student’s t-test, allows the identification of significant differences. The investigations are not only focused on single bacteria, but on the determination of a comprehensive profile. Also, the consideration of the functional microbiome is included in the analyses. The dataset is not from a clinical survey, but very extensive. Results: By examining 946 microbiome profiles of diabetes mellitus type 2 sufferers (272) and healthy control persons (674), a large number of significant genera (25) are revealed. It is possible to identify a large profile for type 2 diabetes disease. Furthermore, it is shown that the diversity of bacteria per taxonomic level in the group of persons with diabetes mellitus type 2 is significantly reduced compared to a healthy control group. In addition, six pathways are determined to be significant for type 2 diabetes describing the fermentation to butyrate. These parameters tend to have high potential for disease detection. Conclusions: With this investigation of the gut microbiome of persons with diabetes type 2 disease, we present significant bacteria and pathways characteristic of this disease.